Notice of Revision to Consolidated Earnings Guidance for the Fiscal Year Ending March 2027

Summary of Revision to Earnings Guidance

Nomura Micro Science Co., Ltd. has revised its consolidated earnings guidance for the fiscal year ending March 2027. Full-year net sales remain unchanged from the previous forecast at 97,000 hundred million yen, and operating income is also unchanged at 16,000 hundred million yen. However, ordinary income has been revised downward to 14,000 hundred million yen, and net income attributable to owners of parent has been revised downward to 10,360 hundred million yen. The interim outlook has been substantially revised to net sales of 24,180 hundred million yen, operating income of 1,132 hundred million yen, ordinary income of -141 hundred million yen, and interim net income attributable to owners of parent of -91 hundred million yen. The revisions are attributed to delayed order timing for a large water treatment equipment project in the United States and cost increases for a project in South Korea.

Outlook and Notes

The company states that while the impact of the first-half order delays is reflected, inquiries by region remain healthy. Although full-year forecast figures were left unchanged, ordinary income and net income attributable to owners of parent are projected to be lower, and further revisions may be made depending on future developments. The progress of the U.S. project and trends in cost management for the Korean project are cited as key factors that will determine future performance.